Your browser doesn't support javascript.
loading
M-CSF as a therapeutic target in BRAFV600E melanoma resistant to BRAF inhibitors.
Barceló, C; Sisó, P; de la Rosa, I; Megino-Luque, C; Navaridas, R; Maiques, O; Urdanibia, I; Eritja, N; Soria, X; Potrony, M; Calbet-Llopart, N; Puig, S; Matías-Guiu, X; Martí, R M; Macià, A.
Afiliação
  • Barceló C; Oncologic Pathology Group, University of Lleida, IRBLleida, Lleida, Spain.
  • Sisó P; Oncologic Pathology Group, University of Lleida, IRBLleida, Lleida, Spain.
  • de la Rosa I; Oncologic Pathology Group, University of Lleida, IRBLleida, Lleida, Spain.
  • Megino-Luque C; Oncologic Pathology Group, University of Lleida, IRBLleida, Lleida, Spain.
  • Navaridas R; Centre of Biomedical Research on Cancer (CIBERONC), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
  • Maiques O; Oncologic Pathology Group, University of Lleida, IRBLleida, Lleida, Spain.
  • Urdanibia I; Centre for Cancer and Inflammation, Barts Cancer Institute, Queen Mary University of London, London, UK.
  • Eritja N; Oncologic Pathology Group, University of Lleida, IRBLleida, Lleida, Spain.
  • Soria X; Oncologic Pathology Group, University of Lleida, IRBLleida, Lleida, Spain.
  • Potrony M; Centre of Biomedical Research on Cancer (CIBERONC), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
  • Calbet-Llopart N; Department of Dermatology, Hospital Universitari Arnau de Vilanova, University of Lleida, IRBLleida, Lleida, Spain.
  • Puig S; Biomedical Research Networking Center on Rare Diseases (CIBERER), ISCIII, Barcelona, Spain.
  • Matías-Guiu X; Biochemistry and Molecular Genetics Department, Hospital Clínic de Barcelona, IDIBAPS, University of Barcelona, Barcelona, Spain.
  • Martí RM; Biomedical Research Networking Center on Rare Diseases (CIBERER), ISCIII, Barcelona, Spain.
  • Macià A; Melanoma Unit, Dermatology Department, Hospital Clínic Barcelona, Universitat de Barcelona, IDIBAPS, Barcelona, Spain.
Br J Cancer ; 127(6): 1142-1152, 2022 10.
Article em En | MEDLINE | ID: mdl-35725813

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Proto-Oncogênicas B-raf / Melanoma Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Proto-Oncogênicas B-raf / Melanoma Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2022 Tipo de documento: Article